MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Townsend, A. J.
Right arrow Articles by Cowan, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Townsend, A. J.
Right arrow Articles by Cowan, K. H.

Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents

AJ Townsend, CP Tu and KH Cowan

Medicine Branch, National Cancer Institute, National Institues of Health, Bethesda, Maryland 20892.

Increased expression of certain glutathione S-transferase (GST) isoenzymes has frequently been associated with the development of resistance to alkylating agents and other classes of antineoplastic drugs in drug-selected cell lines. The question arises whether this phenomenon is causal or is a stress-induced response associated with drug resistance in these cell lines. We have constructed mammalian expression vectors containing the human GST mu and GST alpha 2 (Ha2) cDNAs and stably transfected them into the human breast cancer cell line MCF-7. Whereas the parental and pSV2neo-transfected cell lines display low GST activity, three individual transfected clones were identified in each group that expressed either GST mu or GST alpha 2. The range of GST activities was similar to those observed in cells selected for anticancer drug resistance. The GST mu specific activities were 56, 150, and 340 mlU/mg, compared with 10 mlU/mg of endogenous GST mu in control lines. Specific activities in GST alpha 2-transfected clones were 17, 28, and 52 mlU/mg, compared with no detectable alpha class GST in control lines. These clonal lines and the parental and pSV2neo-transfected control lines were tested for sensitivity to antineoplastic agents and other cytotoxic compounds. The clones with the highest activity in each group were 1.7-fold (GST alpha 2) to 2.1- fold (GST mu) resistant to the toxic effects of ethacrynic acid, a known substrate for GSTs. However, the GST-transfected cell lines were not resistant to doxorubicin, L-phenylalanine mustard, bis(2- chloroethyl)-1-nitrosourea, cisplatin, chlorambucil, or the GST substrates 1-chloro-2,4-dinitrobenzene or tert-butyl hydroperoxide. Thus, although L-phenylalanine mustard, bis(2-chloroethyl)-1- nitrosourea, chlorambucil, tert-butyl hydroperoxide, and 1-chloro-2,4- dinitrobenzene are known to be metabolized by glutathione-dependent GST- catalyzed reactions, there was no protection against any of these agents in MCF-7 cell lines overexpressing GST mu or GST alpha 2. We conclude that, at the levels of GST obtained in this transfection model system, overexpression of GST mu or GST alpha 2 is not by itself sufficient to confer resistance to these anticancer agents. These studies do not exclude the possibility that GST may be a marker of drug resistance or that other gene products not expressed in MCF-7 cells might cooperate with GST to confer drug resistance.

Volume 41, Issue 2, pp. 230-236, 02/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
D. M. Kokkinakis, A. G. Brickner, J. M. Kirkwood, X. Liu, J. E. Goldwasser, A. Kastrama, C. Sander, D. Bocangel, and S. Chada
Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress
Mol. Cancer Res., August 1, 2006; 4(8): 575 - 589.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Depeille, P. Cuq, S. Mary, I. Passagne, A. Evrard, D. Cupissol, and L. Vian
Glutathione S-Transferase M1 and Multidrug Resistance Protein 1 Act in Synergy to Protect Melanoma Cells from Vincristine Effects
Mol. Pharmacol., April 1, 2004; 65(4): 897 - 905.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
P. K. Smitherman, A. J. Townsend, T. E. Kute, and C. S. Morrow
Role of Multidrug Resistance Protein 2 (MRP2, ABCC2) in Alkylating Agent Detoxification: MRP2 Potentiates Glutathione S-Transferase A1-1-Mediated Resistance to Chlorambucil Cytotoxicity
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. GOTO, Y. IHARA, Y. URATA, S. IZUMI, K. ABE, T. KOJI, and T. KONDO
Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase {pi}
FASEB J, December 1, 2001; 15(14): 2702 - 2714.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Panasci, J.-P. Paiement, G. Christodoulopoulos, A. Belenkov, A. Malapetsa, and R. Aloyz
Chlorambucil Drug Resistance in Chronic Lymphocytic Leukemia: The Emerging Role of DNA Repair
Clin. Cancer Res., March 1, 2001; 7(3): 454 - 461.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. S. Morrow, P. K. Smitherman, S. K. Diah, E. Schneider, and A. J. Townsend
Coordinated Action of Glutathione S-Transferases (GSTs) and Multidrug Resistance Protein 1 (MRP1) in Antineoplastic Drug Detoxification. MECHANISM OF GST A1-1- AND MRP1-ASSOCIATED RESISTANCE TO CHLORAMBUCIL IN MCF7 BREAST CARCINOMA CELLS
J. Biol. Chem., August 7, 1998; 273(32): 20114 - 20120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. R. Fields, C. S. Morrow, A. J. Doss, K. Sundberg, B. Jernström, and A. J. Townsend
Overexpression of Stably Transfected Human Glutathione S-Transferase P1-1 Protects against DNA Damage by Benzo[a]pyrene Diol-Epoxide in Human T47D Cells
Mol. Pharmacol., August 1, 1998; 54(2): 298 - 304.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. D. Bunting and A. J. Townsend
De Novo Expression of Transfected Human Class 1 Aldehyde Dehydrogenase (ALDH) Causes Resistance to Oxazaphosphorine Anti-cancer Alkylating Agents in Hamster V79 Cell Lines
J. Biol. Chem., May 17, 1996; 271(20): 11884 - 11890.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. D. Bunting and A. J. Townsend
Protection by Transfected Rat or Human Class 3 Aldehyde Dehydrogenases against the Cytotoxic Effects of Oxazaphosphorine Alkylating Agents in Hamster V79 Cell Lines
J. Biol. Chem., May 17, 1996; 271(20): 11891 - 11896.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics